Riboscience, Llc.
Clinical trials sponsored by Riboscience, Llc., explained in plain language.
-
New hope for liver cancer: combo therapy aims to shrink tumors
Disease control Recruiting nowThis study tests a new drug (RBS2418) added to a standard immunotherapy combination (tremelimumab plus durvalumab) for people with advanced liver cancer that cannot be removed by surgery. The goal is to see if the new combo helps control the cancer longer and shrinks tumors. Abou…
Phase: PHASE2 • Sponsor: Riboscience, LLC. • Aim: Disease control
Last updated May 26, 2026 05:51 UTC
-
New drug RBS2418 aims to supercharge immune system against tumors
Disease control Recruiting nowThis study tests an experimental drug called RBS2418, which works by helping the body's immune system fight cancer more effectively. It is given alone or with another cancer drug (pembrolizumab) to people with advanced solid tumors that have not responded to standard treatments. …
Phase: PHASE1 • Sponsor: Riboscience, LLC. • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New drug aims to rally immune system against tough colorectal cancer
Disease control Recruiting nowThis study tests an experimental drug called RBS2418 in people with advanced colorectal cancer that has spread and is no longer responding to standard treatments. The drug works by helping the body's immune system recognize and attack cancer cells. About 150 adults will receive e…
Phase: PHASE2 • Sponsor: Riboscience, LLC. • Aim: Disease control
Last updated May 22, 2026 13:53 UTC